Volume 3, Issue 1 (February 2016)                   IJML 2016, 3(1): 50-63 | Back to browse issues page

XML Print


Department of Microbiology, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
Abstract:   (2079 Views)

Background and Aims: Acinetobacter baumannii is regarded as an important nosocomial pathogen around the world, especially in the intensive care unit that today seems to be resistant to the most antibiotics. Therefore, this study aimed to trace classes 1, 2, and 3 integrin in the isolates resistant to Acinetobacter baumannii.

Materials and Methods: In this descriptive study, Acinetobacter baumannii of 67 patients in Ahvaz hospitals were all isolated and their antibiotic resistance pattern was determined by the disk diffusion. The presence of genes coding for antibiotic resistance as well as integrons (class 1, 2 and 3) were analyzed using polymerase chain reaction method.

Results: Out of 67 isolates, the most resistance was observed for the antibiotic tetracycline (89.5%) and the most sensitivity to antibiotic was reported for chloramphenicol, meropenem and nitrofurantoin (2.9%). The distribution of dfrA1, sul1, aac(3)-IV, tet(B), tet(A), aadA1, blaCITM, vim, qnr, blaSHV, sim, Oxa-24-like, Oxa-51-like, Oxa-58-like, Oxa-23-like, imp, cmlA and cat1 were 42 (62.6%), 40 (59.7%), 36 (53.7%), 34 (50.7%), 31 (46.2%), 17 (25.3%), 17 (25.3%), 16 (23.8%), 11 (16.4%), 11 (16.4%), 8(11.9%), 5(7.4%), 5(7.4%), 4 (5.9%),4 (5.9%), 4 (5.9%), 2 (2.9%), 1 (1.4%) respectively. Moreover, frequency of class 1, II and III integrons was 67 (100%), 22 (32.8%), and 3 (4.4%) respectively.

Conclusions: High prevalence of integrons among Acinetobater baumannii isolated strains in Ahvaz hospitals indicate the importance role of integrons in multidrug resistance in this bacteria. Therefore, unnecessary use of antibiotics are recommended to be avoided.


Full-Text [PDF 739 kb]   (925 Downloads)    
Type of Study: Research | Subject: Bactriology
Received: 2016/03/17 | Accepted: 2016/03/17 | Published: 2016/03/17

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.